Evidence map›Paper›PMID 35037468›Full record

ArticleAmerican journal of physiology. Renal physiology2022

Zebrafish (

Jan Stephan Bolten, Anna Pratsinis, Claudio Luca Alter, Gert Fricker, Jörg Huwyler

Open access · hybridAbstract read
In one paragraph

Article in American journal of physiology. Renal physiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Principles of Zebrafish Nephron Segment Development.Journal of developmental biology · 2023
    Review
  5. Review
  6. Review
  7. Article
  8. Biomedicines · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 3 countries.

Jan Stephan BoltenDepartment of Pharmaceutical Sciences, University of Basel, Basel, Switzerland.
Anna PratsinisDepartment of Pharmaceutical Sciences, University of Basel, Basel, Switzerland.
Claudio Luca AlterDepartment of Pharmaceutical Sciences, University of Basel, Basel, Switzerland.
Gert FrickerInstitute of Pharmacy and Molecular Biotechnology, University of Heidelberg, Heidelberg, Germany.
Jörg HuwylerDepartment of Pharmaceutical Sciences, University of Basel, Basel, Switzerland.ORCID 0000-0003-1748-5676
University of Basel · CHHeidelberg University · DE

Funding

The Maine Biomedical Research Network (INBRE)P20GM103423 · NIGMS · MOUNT DESERT ISLAND BIOLOGICAL LAB · PI Dustin Lynn Updike · 2012 to 2026
$60.0M
Maine INBRE grant GM103423NIGMS NIH HHS P20 GM103423
6 · The paper itself

Abstract

There is an increasing interest in using zebrafish (

Indexed as

AnimalsAnimals, Genetically ModifiedATP-Binding Cassette, Sub-Family C ProteinsEmbryonic DevelopmentFluorescent DyesGene Expression Regulation, DevelopmentalGreen Fluorescent ProteinsLarvaLuminescent ProteinsMembrane Transport ProteinsMicroscopy, ConfocalMultidrug Resistance-Associated Protein 2NephronsOrganic Cation Transport ProteinsProof of Concept StudyRed Fluorescent ProteinAbcc4 protein, zebrafishATP-Binding Cassette, Sub-Family C Proteinsenhanced green fluorescent proteinFluorescent DyesGreen Fluorescent ProteinsLuminescent ProteinsMembrane Transport ProteinsMultidrug Resistance-Associated Protein 2multi-resistance associated protein 1, zebrafishOrganic Cation Transport ProteinsRed Fluorescent ProteinZebrafish Proteinsdrug transporterglomerular filtrationkidney tubulerenal functionzebrafish

Identifiers

PMID35037468
PMCPMC8858672
OpenAlexW4206422564

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.